NCAPH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.169600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.065800E-01
Normal-vs-Stage2
3.493600E-01
Normal-vs-Stage3
7.970800E-01
Normal-vs-Stage4
7.242800E-01
Stage1-vs-Stage2
2.545800E-01
Stage1-vs-Stage3
8.815600E-01
Stage1-vs-Stage4
7.655000E-01
Stage2-vs-Stage3
4.346800E-01
Stage2-vs-Stage4
5.558600E-01
Stage3-vs-Stage4
8.731200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.101400E-01
Normal-vs-AfricanAmerican
5.894200E-01
Normal-vs-Asian
4.898200E-01
Caucasian-vs-AfricanAmerican
5.941400E-01
Caucasian-vs-Asian
2.383600E-01
AfricanAmerican-vs-Asian
9.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.179000E-01
Normal-vs-Female
4.116400E-01
Male-vs-Female
3.348800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.913000E-01
Normal-vs-Age(41-60Yrs)
4.240600E-01
Normal-vs-Age(61-80Yrs)
4.112600E-01
Normal-vs-Age(81-100Yrs)
3.539600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.463800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.090400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.904400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.437200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.868000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.822200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.203400E-01
Normal-vs-Daily Drinker
5.819400E-01
Normal-vs-Weekly Drinker
4.650000E-01
Normal-vs-Occasional Drinker
3.538000E-01
Normal-vs-Social Drinker
3.738200E-01
Non Drinker-vs-Daily Drinker
6.107400E-01
Non Drinker-vs-Weekly Drinker
3.827000E-01
Non Drinker-vs-Occasional Drinker
6.154200E-01
Non Drinker-vs-Social Drinker
4.600600E-01
Daily Drinker-vs-Weekly Drinker
2.700800E-01
Daily Drinker-vs-Occasional Drinker
2.984800E-01
Daily Drinker-vs-Social Drinker
2.293800E-01
Weekly Drinker-vs-Occasional Drinker
5.404000E-01
Weekly Drinker-vs-Social Drinker
6.764800E-01
Occasional Drinker-vs-Social Drinker
7.786600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.684800E-01
Normal-vs-Grade 2
6.210800E-01
Normal-vs-Grade 3
6.594200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.341500E-03
Grade 1-vs-Grade 3
5.55019999999296E-05
Grade 1-vs-Grade 4
5.684800E-01
Grade 2-vs-Grade 3
5.106400E-02
Grade 2-vs-Grade 4
6.210800E-01
Grade 3-vs-Grade 4
6.594200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.469200E-01
Normal-vs-NonDiabetic
4.352800E-01
Diabetic-vs-NonDiabetic
5.470200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.548400E-01
Normal-vs-NoPancreatitis
4.790800E-01
Pancreatitis-vs-NoPancreatitis
8.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.583600E-01
Normal-vs-N1
3.760400E-01
N0-vs-N1
3.551200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.523570E-01
Normal-vs-TP53-NonMutant
6.235800E-01
TP53-Mutant-vs-TP53-NonMutant
3.56500000000537E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
